Inspire Medical Systems Faces Securities Investigation
Analysis based on 9 articles · First reported Feb 01, 2026 · Last updated Feb 14, 2026
The market is negatively impacted by the news of Inspire Medical Systems' operational issues and subsequent legal challenges, leading to a significant drop in its stock value and investor confidence. The investigation by Kahn Swick & Foti, LLC adds further uncertainty for investors.
Kahn Swick & Foti, LLC (KSF), a prominent securities litigation law firm, has initiated an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). This investigation follows a securities class action lawsuit against Inspire Medical Systems and its executives, charging them with failing to disclose material information in violation of federal securities laws. The issues stem from Inspire Medical Systems' August 2025 disclosure that the launch of its Inspire V device faced an 'elongated timeframe' due to previously undisclosed problems, including incomplete training and onboarding criteria at many centers, delayed software updates for claims submissions, and excess inventory leading to poor demand. As a result, Inspire Medical Systems drastically cut its 2025 earnings guidance by over 80%. KSF's investigation focuses on whether Inspire Medical Systems' officers and/or directors breached their fiduciary duties to shareholders.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard